U.S. patent number 3,836,129 [Application Number 05/281,772] was granted by the patent office on 1974-09-17 for evaporator for liquid anesthetics.
Invention is credited to Alexandr Zinovievich Berlin, Igor Konstantinovich Gorlin, Alexandr Semenovich Perelmutr, Alexandr Gustavovich Traxler.
United States Patent |
3,836,129 |
Perelmutr , et al. |
September 17, 1974 |
EVAPORATOR FOR LIQUID ANESTHETICS
Abstract
An evaporator for liquid narcotics, comprising a straight-flow
by-pass duct, wherein provision is made for a shutter and a control
slide which, when in one of the extreme positions, interacts with
the shutter to close gas admission into the by-pass duct, and an
evaporating chamber. The latter is made as a circular straight-flow
channel embracing the by-pass duct and is provided with
capillary-structure evaporating elements arranged inside the
chamber lengthwise the gas flow lines, and with an effuser provided
at the outlet of the chamber concentrically to the shutter so as to
establish an annular gap therebetween. The control slide, when in
the other extreme position, interacts with the effuser to shut up
gas issue from the evaporating chamber.
Inventors: |
Perelmutr; Alexandr Semenovich
(Moscow, SU), Berlin; Alexandr Zinovievich (Moscow,
SU), Gorlin; Igor Konstantinovich (Moscow,
SU), Traxler; Alexandr Gustavovich (Moscow,
SU) |
Family
ID: |
23078723 |
Appl.
No.: |
05/281,772 |
Filed: |
August 18, 1972 |
Current U.S.
Class: |
261/47;
128/203.25; 261/DIG.65; 261/102; 261/104; 261/153 |
Current CPC
Class: |
A61M
16/18 (20130101); B01D 1/00 (20130101); A61M
2205/3368 (20130101); Y10S 261/65 (20130101) |
Current International
Class: |
A61M
16/10 (20060101); A61M 16/18 (20060101); B01D
1/00 (20060101); B01d 001/06 () |
Field of
Search: |
;128/188,187,186,194,196,197,209,210
;261/104,105,47,63,107,102,104,153,DIG.65 |
References Cited
[Referenced By]
U.S. Patent Documents
Primary Examiner: Juhasz; Andrew R.
Assistant Examiner: Briggs; W. R.
Attorney, Agent or Firm: Waters; Eric H.
Claims
What is claimed is:
1. An evaporator for liquid narcotics, comprising: a straight-flow
by-pass duct; a fixed shutter provided in said by-pass duct at one
of the ends thereof; an evaporating chamber having inlet and an
outlet openings, said chamber being formed as an annular
straight-flow channel encompassing said by-pass duct and
communicating with the latter through said openings; evaporating
elements having a capillary structure being postioned along said
chamber; a generally cylindrically shaped control slide with a
tapered portion at the exit end thereof longitudinally movably
received in said by-pass duct whereby the by-pass fluid flow passes
through said control slide and around said shutter; and an effuser
located at the outlet of said chamber, said tapered portion being
externally shaped in conformance with the profile of said effuser;
said effuser being positioned such that the fluid flows from the
by-pass duct and evaporating chamber are directed to converge in
correspondent directions.
2. An evaporator as claimed in claim 1, said evaporating elements
adhering to the surface of said evaporating chamber.
3. An evaporator as claimed in claim 1, said tapered portion of the
control slide being adapted to operatively interact with said
effuser.
Description
This invention relates generally to medical equipment and has
particular reference to evaporators for liquid narcotics
(anesthetics) adapted for proportioning evaporable anesthetics used
in inhalation narcosis at surgical and anesthesiological
departments.
Known in present-day practice is one prior-art evaporator for
liquid narcotics, comprising an evaporating chamber with
capillary-structure evaporating elements, a straight-flow by-pass
duct with an obturator or shutter and a control slide.
The evaporating chamber of the prior evaporator is shaped as a
teaglass which with one of its end faces bears against the outside
wall of the by-pass duct and communicates therewith through an
inlet and outlet openings. The evaporating elements of said chamber
are made as a metal gauze adhering to the walls and bottom of the
chamber, the latter being essentially a container with
thermostabilizing liquid, the flow of gas in the chamber occurring
along V-shaped pattern.
The telescopic spool-type slide has at one of its ends an inside
narrowed portion shaped to suit the form of the shutter and is
adapted, when in one of the extreme positions, to interact with the
shutter to close the admission of gas to the by-pass duct.
The afore-said evaporator, however, suffers from a number of
disadvantages such as different contours of the cross-sectional
areas of the evaporating chamber and of the by-pass duct, as well
as different lengths of the gas flow lines in the evaporating
chamber and in the by-pass duct which eventuates in different
hydromechanical characteristics of said lines and, finally, in an
unstable gas flow division at variations in the total flow rate of
gas through the evaporator, pulsations of the gas flow resulting
from spontaneous respiration or from a pressure in the patient's
respiratory circuit during artifical ventilation of the lungs.
Moreover, the arrangement of the evaporating elements along the
walls and bottom of the evaporating chamber fails to obtain high
gradients of concentration of the anesthetic in gas which fact in
conjunction with too small evaporation area confined to the
evaporator size and its incomplete utilization, leads to an
inadequate saturation of gas with the vapours of anesthetic at high
gas consumption rate.
Unstable gas flow division and insufficient gas saturation at the
outlet of the evaporating chamber results in unstable proportioning
of anesthetics, especially when using the same evaporator for
various anesthetics.
It is an essential object of the present invention to provide an
evaporator for liquid narcotics, whose evaporating chamber features
hydromechanical characteristics similar to those of the by-pass
duct and is capable of ensuring an equilibrium gas saturation with
the vapours of any liquid narcotics.
Said object is accomplished due to the fact that in an evaporator
for liquid narcotics, comprising an evaporating chamber with
capillary-structure evaporating elements communicating through
inlet and outlet openings with a straight-flow by-pass duct,
wherein provision is made for a shutter and a control slide which
is adapted, when in one of its extreme positions to interact with
said shutter to close gas admission to the by-pass duct, according
to the invention the evaporating chamber is made as a circular
straight-flow channel embracing the by-pass duct, the evaporating
elements are arranged lengthwise the gas flow lines, and the
chamber is provided with an effuser located at the outlet thereof
concentrically with the shutter so as to form an annular gap
therewith, whereas the control slide, when in the other extreme
position, interacts with the effuser to shut off the issue of gas
from the evaporating chamber.
It is expedient that the evaporating elements be made as channel
bars with their side walls bearing against the chamber walls.
It is likewise desirable that the slide end interacting with the
effuser be provided with an external narrowing shaped to suit the
shape of the effuser, while the other slide end be made threaded to
interact with the slide motion nut.
The evaporator for anesthetics as implemented according to the
present invention, features similar hydromechanical characteristics
of the evaporating chamber and the by-pass duct thereof, and thus
ensure an equilibrium gas saturation with the vapours of any
anesthetics.
In what follows the invention is disclosed in detail through the
consideration of a specific embodiment thereof with due reference
to the accompanying drawings, wherein:
FIG. 1 is a sectional view of an evaporator for liquid narcotics,
according to the invention; and
FIG. 2 is a section taken along the line II--II in FIG. 1.
Now referring to FIG. 1 the evaporator comprises an evaporating
chamber 1 made as a circular straight-flow channel embracing a
straight-flow by-pass duct 2 at whose outlet end a shutter 3 is
provided. The shutter 3 is fixed to a stem 4 having at its ends
fairings 5 and 6 to reduce gas flow resistance at the evaporator
inlet and outlet, and a headpiece 7 adapted to correct the
dependance of the pressure differential upon the gas flow rate
through the by-pass duct 2. An effuser 8 is made fast at the outlet
of the evaporating chamber 1 concentrically with the shutter 3, an
annular gap 9 being left therebetween. The effuser 8 passes into an
outlet nozzle 10 of the evaporator. Located in the by-pass duct 2
is a control slide 11 made as a thin-walled tube with a tapered
portion 12 at one end, said tapered portion being internally shaped
to suit the profile of the shutter 3 and externally shaped to suit
the profile of the effuser 8. At its other end the control slide 10
passes into an inlet nozzle 13 provided with male thread.
The evaporating chamber has two rows of openings 14 and 15 located
at its ends along the periphery of an inside wall 16 and serving as
the inlet and the outlet openings 14 and 15, respectively. A
container 17 with liquid anesthetic is provided at the outlet end
of the evaporating chamber 1. The chamber 1 is provided with a
thermometer 18 located nearby the outlet openings 15, and is
enclosed with a jacket 19 along which thermostabilizing liquid
circulates whose functions are performed by water. Located inside
the evaporating chamber 1 are capillary evaporating elements 20
arranged lengthwise the gas flow line. Use is made in the
now-discussed embodiment of the invention as the evaporating
elements 20, of channel bars made of a porous sheet material, viz.,
stainless steel. With their side walls the channel bars adhere to
the walls of the chamber 1 and with one of their ends said bars are
immersed in the container 17 with anesthetic.
The channel bars partition the chamber 1 into longitudinal
compartments 21 (FIG. 2) parallel to one another.
The inlet nozzle 13 (FIG. 1) interacts with a nut 22 by virtue of
its thread, said nut being mounted rotatably on a cover 23 of the
evaporating chamber 1. The nut 22 is provided with a replaceable
scale 24 calibrated with due allowance for the outlet temperature
of the evaporating chamber 1. The control slide 11 has slits 25
adapted to interact with the inlet openings of the chamber 1.
Gas flow resistance (i.e., pressure differential) in the flow path
of the evaporating chamber 1 is concentrated at the outer annular
gap in between the effuser 8 and the tapered portion 12 of the
control slide 11, while the resistance in the flow path of the
by-pass duct 2, at the inner annular gap in between the tapered
portion 12 and the shutter 3.
Relationship between the pressure differential and the gas flow
rate through the chamber 1 and the by-pass duct 2 is approximately
linear.
The evaporating elements 20 may also be made as thin-walled tubes
of porous metal, spaced at a clearance with one another and having
openings located opposite to the outlet openings 15 of the
evaporating chamber 1, or else made as a spiral provided with
similar openings.
The evaporator of the present invention functions as follows.
To suit the required concentration of anesthetic, the control slide
11 (FIG. 1) is set, by rotating the nut 22 with the scale 24, to
the position ensuring the required ratio of the gas flow rates
through the chamber 1 and the by-pass duct 2, said ratio being
dependent upon the ratio of the cross-sectional areas of the outer
annular gap (in between the effuser 8 and the tapered portion 12)
and the inner annular gap (in between the tapered portion 12 and
the shutter 3).
Gas (which may be in fact the air inhaled by the patient, or a gas
mixture fed from any extraneous source) is delivered to the
evaporator via the inlet nozzle 13 to pass in between the shutter 5
and the control slide 11, whereupon the gas flow is divided into
two streams, of which one is directed through the slits 25 and the
openings 14 into the chamber 1, wherein the gas is spread over the
compartments 21 (FIG. 2) and passes along the channel bars from the
inlet of the chamber 1 (FIG. 1) towards the outlet thereof. While
passing the gas gets saturated with the anesthetic till an
equilibrium saturation thereof which is equal to the ratio of the
partial pressure of saturated vapours of the anesthetic and the
ambient pressure at the temperature measured by the thermometer
18.
Liquid anesthetic is fed from the container 17 to the evaporating
surface of the channel bars along the capillaries running through
the bulk of the porous sheet material.
Gaseous mixture saturated with the vapours of anesthetic at an
equilibrium concentration, emerges from the chamber 1 via the
openings 15, passes along the inner annular gap in between the
effuser 8 and the tapered portion 12 and is diluted to the required
concentration by another stream of gas flowing along the by-pass
duct 2 in between the control slide 11 and its tapered portion 12,
on one side and in between the stem 4, the headpiece 7 and the
shutter 3, on the other side. The thus-obtained narcotic mixture
emerges from the evaporator through the outlet nozzle 10 and is fed
to the patient.
When in one of its extreme positions corresponding to the maximum
reading of the scale 24, the control slide 11 rests with the inner
surface of the tapered portion 12 against the shutter 3 so that the
entire gas flow passes through the chamber 1, thus
equilibrium-saturated with the vapours of anesthetic.
When in the other extreme position corresponding to the zero mark
of the scale 24, the control slide 11 seats with the outer surface
of the tapered portion 12 on the effuser 8; at the same time the
openings 14 of the chamber 1 are shut up by the spool of the
control slide 11 and the whole flow of gas is free to pass through
the by-pass duct 2.
Heat required for evaporation of liquid anesthetic is fed to the
evaporating elements 20 from the thermostabilizing liquid
circulating through the jackets 19, as well as from the environment
space and the gas passing through the evaporator.
Thus, stable flow division of the gas fed into the evaporator and
an equilibrium saturation of part thereof passing through the
evaporating chamber 1, with the vapours of anesthetic, ensure
independency of the concentration of anesthetic at the outlet of
the proposed evaporator, or extrinsic factors liable to affect said
concentration. To such factors may be attributed gas flow-rate
variations, pulsation of gas flow during spontaneous respiration,
pressure fluctuations in the patient's respiratory circuit during
artifical ventilation of the lungs, different physical properties
of anesthetics. Provision of a thermometer in the evaporating
chamber ensures temperature correction of the outlet
concentration.
The proposed small-sized evaporator weighing about 2 kg, is capable
of an accurate proportioning of any evaporable anesthetic, such as
fluoroethane, diethyl ether, methoxyflurane (pentrane), chloroform,
trichloroethylene, within the range of gas flow rate of from 2 to
15 1/min (in case of constant flow) and from 4 to 12 1/min (in case
of pulsating flow) at temperatures of from +5 to +30.degree.C; the
hydraulic resistance offered by the evaporator is as low as 10 mm
H.sub.2 O at a constant flow rate of 25 1/min, the amount of
residual liquid anesthetic in the evaporating chamber after its
drainage is about 5 ml.
* * * * *